Infanrix Kills and Maims, but GSK Hid It from Doctors & Parents

Infanrix Kills and Maims, but GSK Hid It from Doctors & Parents









GSK wanted to keep the public from knowing about the
adverse effects of their Infanrix vaccine. The secret report slipped
out, and it’s revealing. It validates the recent study showing that
multiple vaccine doses increase the death rate by 50%—but there’s no
real change to the safety advice.


Gardem pf GSK Secrets, by Catarina Carneiro de Sousa
Original cropped, text & GSK logos added
Creative Commons Share & Share Alike License, must give credit to Catarina Carneiroto reuse


by Heidi Stevenson

Infanrix is a vaccine that was released without any serious testing
for safety, in spite of the fact that it contains antigens of six
diseases for injection into babies as young as two months. In a cozy
relationship with government, GlaxoSmithKline (GSK) was able to keep
information about harm from the public. Fortunately, that secrecy was
broken with the leak of a report given to the Belgian government.
It delineates 1,742 adverse events associated with Infanrix^[1].

Adverse Events


These are adverse effects that were reported to GSK. The information
is not pretty—especially when you realize that the vast majority of
vaccine injuries are never reported and that deaths counted included
only sudden death. First, though, let’s just take a quick look at what
the report admitted happened over the two-year period from 23 October
2009 through 22 October 2011:


That silly ol’ document showing all that nasty stuff
that could happen? Don’t fret your little head over it! After all, you
really weren’t supposed to know, anyway. Don’t worry. Trust us!

• 825 adverse effects were identified.
  
• 36 deaths occurred.
  
• Adverse events include autism, encephalitis, heart failure, gaze
  palsy (indicative of neurological damage), gastrointestinal hemorrhage,
  jaundice, mental retardation (classed as not serious!), removal of part
  of the intestine (also defined as not serious!), opisthotonos (yet again labeled as not serious!), paralysis. Guillain Barré syndrome, convulsions, and many others.
  

Naturally, not all the reported events were actually caused by
Infanrix. GSK reported that the number of reported adverse events was
only 14.6 per 100,000. However, as reported by Initiative Citoyenne, the
doctors’ publication, Revue française du Practicien, reports that this figure is likely only 1-10% of the reality^[2].

Spinning and Twisting the Results


On page 11 of the report, GSK unequivocally states that they are the arbiters of what constitutes a serious event^[1]. As noted above, though, they classed mental retardation, opisthotonos, and removal of part of the intestine as not serious!

You have to wonder just how twisted other aspects of the report might
be—and we don’t need to go far to see. GSK decided to add only one
reference of additional risk to their Reference Safety Information. The
only thing they decided to add was syncope (fainting), and even then
they attempted to minimize it by stating:

<blockquote>Syncope (fainting) can occur following, or even before,
any vaccination as a psychogenic response to the needle injection. It is
important that procedures are in place to avoid injury from faints.
</blockquote>
They deprecate the seriousness of fainting, which can be indicative
of severe adverse effects, such as neurological damage, by saying that
any vaccination can cause it and, worse, that it’s just an emotional
reaction. There seems to be no limit to the degree that GSK will go in
its effort to whitewash Infanrix.

Gaze Palsy


Gaze palsy is a condition in which the eyes cannot track together.
It’s generally indicative of brain damage. The report states that the
European Medicines Agency has expressed concern about reports of
Infanrix in association with this disorder. Therefore, the report
specifically covers the problem.

The first question that comes to mind is: Why didn’t the EMA notify
the public that there is some concern about Infanrix and this disorder?
Surely, if the agency exists to protect the public, then any concern it
has about Infanrix would be expressed so that parents could decide how
to proceed. That, though, hasn’t happened.

GSK provides a large table listing 70 reported gaze palsy cases with
associated symptoms. These include loss of consciousness, convulsion,
spasms, cyanosis, opisthotonos, extrapyramidal disorder, and epilepsy. Most of these symptoms showed up in many cases. 45 of the 70 cases occurred on the day of vaccination.

They indicate that most of the cases cleared up without sequelae. Of
course, they don’t spend any time on follow-up. What would have shown up
if they’d watched these children for 2-5 years? Would brain damage then
become more obvious?

Implications


It is now clear from a recent study that more doses of vaccines at
one time result in significantly greater risk to health. As reported in
Gaia Health, the mortality rate in children who have 5-8 vaccine doses
at one time have a death rate that’s 50% greater than those who are
given 1-4 vaccine doses^[3].

That’s a highly significant risk. The study doesn’t focus on the specific causes of death, but instead clarifies that multivalent
vaccines equate to seriously damaged health. The study also revealed
that children with double the number of vaccine doses were twice as
likely to be hospitalized.

The five antigen doses of Infanrix are in the range of the 5
to 8 doses that the study found cause 50% more child deaths and double
the hospitalizations.

Your Right to Know?


Do you think there’s a right to know the risks of a vaccine before
it’s administered? Do you think you should be informed that Infanrix can
cause convulsions, epilepsy, autism, and a wide range of other
devastating and life destroying damage?

In fact, the official document for the public goes to great lengths
to indicate that there’s no excess risk with Infanrix. Aside from the
standard boilerplate type of commentary, here’s what it says^[4]:

<blockquote>A history of febrile convulsions, a family history of convulsions or Sudden Infant Death Syndrome (SIDS) do not constitute a contraindication for the use of Infanrix hexa. … [Emphasis mine]

… HIV infection is not considered as a contraindication. …

… Limited data in 169 premature infants indicate that Infanrix hexa can be given to premature children …

… Infanrix hexa should be administered with caution to subjects with
thrombocytopenia or a bleeding disorder since bleeding may occur
following an intramuscular administration to these subjects.
</blockquote>
Of course, they may add a little note about the possibility of
fainting, but there’s no need to worry! It’s just a psychological thing,
something that could happen with any vaccine.

The approach is little more than a come-one-come-all carnival-like
bid to get you in the door with Jen’s or Jeff’s arm, leg, or other body
part sticking out, ready for administration of yet another toxic assault
on your child.

That silly ol’ document showing all that nasty stuff that could happen? Don’t fret your little head over it! After all, you really weren’t supposed to know, anyway. Don’t worry. Trust us!

You surely don’t want to wander through GSK’s Garden of Secrets, do you?


Source:-
http://gaia-health.com/gaia-blog/2013-01-20/gsk-secret/